Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon J Freeman

Showing results (141-150 of 348) with videos related to

Pageof 35
Sort By:
Blood Advances|November 13, 2019
Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantationBettina P Iliopoulou, Katie Hsu, Magdiel Pérez-Cruz, et al.
The Journal of Urology|May 11, 2017
Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic ImplicationsStephanie A M Wankowicz, Lillian Werner, Anna Orsola, et al.
The Journal of Allergy and Clinical Immunology|February 1, 2019
Blockade of RGMb inhibits allergen-induced airways diseaseSanhong Yu, Krystle M Leung, Hye-Young Kim, et al.
International Journal of Cancer|December 6, 2018
Anti-PD-1/PD-L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancerViswanath Gunda, Benjamin Gigliotti, Tameem Ashry, et al.
Cancer Immunology Research|November 8, 2015
PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor CellsKathleen M Mahoney, Heather Sun, Xiaoyun Liao, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 30, 2016
Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient MiceAmanda C Foks, Daniel Engelbertsen, Felicia Kuperwaser, et al.
Nature Immunology|December 2, 2008
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infectionShawn D Blackburn, Haina Shin, W Nicholas Haining, et al.
The Journal of Clinical Investigation|May 17, 2013
PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cellsErin E West, Hyun-Tak Jin, Ata-Ur Rasheed, et al.
Nature Communications|March 27, 2015
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidationNikolaos Patsoukis, Kankana Bardhan, Pranam Chatterjee, et al.
European Journal of Immunology|October 28, 2003
Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysisNancy Rodig, Timothy Ryan, Jessica A Allen, et al.
Pageof 35

Showing results (141-150 of 348) with videos related to

Sort By:
Pageof 35
Blood Advances|November 13, 2019
Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantationBettina P Iliopoulou, Katie Hsu, Magdiel Pérez-Cruz, et al.
The Journal of Urology|May 11, 2017
Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic ImplicationsStephanie A M Wankowicz, Lillian Werner, Anna Orsola, et al.
The Journal of Allergy and Clinical Immunology|February 1, 2019
Blockade of RGMb inhibits allergen-induced airways diseaseSanhong Yu, Krystle M Leung, Hye-Young Kim, et al.
International Journal of Cancer|December 6, 2018
Anti-PD-1/PD-L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancerViswanath Gunda, Benjamin Gigliotti, Tameem Ashry, et al.
Cancer Immunology Research|November 8, 2015
PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor CellsKathleen M Mahoney, Heather Sun, Xiaoyun Liao, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 30, 2016
Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient MiceAmanda C Foks, Daniel Engelbertsen, Felicia Kuperwaser, et al.
Nature Immunology|December 2, 2008
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infectionShawn D Blackburn, Haina Shin, W Nicholas Haining, et al.
The Journal of Clinical Investigation|May 17, 2013
PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cellsErin E West, Hyun-Tak Jin, Ata-Ur Rasheed, et al.
Nature Communications|March 27, 2015
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidationNikolaos Patsoukis, Kankana Bardhan, Pranam Chatterjee, et al.
European Journal of Immunology|October 28, 2003
Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysisNancy Rodig, Timothy Ryan, Jessica A Allen, et al.
Pageof 35